Substrate-Dependence of Competitive Nucleotide Pyrophosphatase/Phosphodiesterase1 (NPP1) Inhibitors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Substrate-Dependence of Competitive Nucleotide Pyrophosphatase/Phosphodiesterase1 (NPP1) Inhibitors

Published:2017-02-15 Issue: Volume:8 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Lee Sang-Yong,Sarkar Soumya,Bhattarai Sanjay,Namasivayam Vigneshwaran,De Jonghe Steven,Stephan Holger,Herdewijn Piet,El-Tayeb Ali,Müller Christa E.

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference58 articles.

1. Mechanisms of disease: ectonucleotide pyrophosphatase phosphodiesterase 1 as a “gatekeeper” of insulin receptors;Abate;Nat. Clin. Pract. Endocrinol.,2006

2. The expression of ecto-nucleotide pyrophosphatase/phosphodiesterase 1 (E-NPP1) is correlated with astrocytic tumor grade;Aerts;Clin. Neurol. Neurosur.,2011

3. Therapeutic potentials of ecto-nucleoside triphosphate diphosphohydrolase, pyrophosphatase / phosphodiesterase, ecto-5 -nucleotidase, and alkaline phosphate inhibitors;Al-Rashida;Med. Res. Rev.,2013

4. CD39 and CD73 in immunity and inflammation;Antonioli;Trends Mol. Med.,2013

5. Two pathways for lysophosphatidic acid production;Aoki;Biochim. Biophys. Acta,2008

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insight into small-molecule inhibitors targeting extracellular nucleotide pyrophosphatase/phosphodiesterase1 for potential multiple human diseases;European Journal of Medicinal Chemistry;2024-03

2. Ecto-nucleotide pyrophosphatase/phosphodiesterase 1 inhibitors: Research progress and prospects;European Journal of Medicinal Chemistry;2024-03

3. Discovery of Pyrido[2,3-d]pyrimidin-7-one Derivatives as Highly Potent and Efficacious Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 (ENPP1) Inhibitors for Cancer Treatment;Journal of Medicinal Chemistry;2024-02-22

4. Naturally occurring quercetin and myricetin as potent inhibitors for human ectonucleotide pyrophosphatase/phosphodiesterase 1;Scientific Reports;2024-01-02

5. Heparins are potent inhibitors of ectonucleotide pyrophosphatase/phospho-diesterase-1 (NPP1) – a promising target for the immunotherapy of cancer;Frontiers in Immunology;2023-08-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3